7. Brack-Werner, R., A. Kleinschmidt, A. Ludvigsen, W. Mellert, M. Neumann, 31.
R. Herrmann, M. C. Khim, A. Burny, N. Muller-Lantzsch, and D. Stavrou.
1992. Infection of human brain cells by HIV-1: restricted virus production in
chronically infected human glial cell lines. AIDS 6:273–285. 32.
8. Budka, H., and H. Lassmann. 1988. Human immunodeficiency virus in glial
cells? J. Infect. Dis. 157:203–205.
9. Campagnoni, A. T. 1988. Molecular biology of myelin proteins from the
central nervous system. J. Neurochem. 51:1–14. 33.
10. Coetzee, T., N. Fujita, J. Dupree, R. Shi, A. Blight, K. Suzuki, and B. Popko.
1996. Myelination in the absence of galactocerebroside and sulfatide: normal
structure with abnormal function and regional instability. Cell 86:209–219. 34.
11. Coetzee, T., K. Suzuki, and B. Popko. 1998. New perspectives on the function
of myelin galactolipids. Trends Neurosci. 21:126–130.
12. Dal Pan, G. J., J. D. Glass, and J. C. McArthur. 1994. Clinicopathologic
correlations of HIV-1-associated vacuolar myelopathy: an autopsy-based 35.
case-control study. Neurology 44:2159–2164.
13. Davies, K. 1993. The cause of Canavan's disease. Nature 365:590.
14. Eilbott, D. J., N. Peress, H. Burger, D. LaNeve, J. Orenstein, H. E. S. R. 36.
Gendelman, and B. Weiser. 1989. Human immunodeficiency virus type 1 in
spinal cords of acquired immunodeficiency syndrome patients with myelopathy: expression and replication in macrophages. Proc. Natl. Acad. Sci. USA
86:3337–3341. 37.
15. Esiri, M., C. S. Morris, and P. R. Millard. 1991. Fate of oligodendrocytes in
HIV-1 infection. AIDS 5:1081–1088. 38.
16. Gosztonyi, G., J. Artigas, L. Lamperth, and H. D. Webster. 1994. Human 39.
immunodeficiency virus (HIV) distribution in HIV encephalitis: study of 19
cases with combined use of in situ hybridization and immunocytochemistry.
J. Neuropathol. Exp. Neurol. 53:521–534.
17. Goudreau, G., S. Carpenter, N. Beaulieu, and P. Jolicoeur. 1996. Vacuolar 40.
myelopathy in transgenic mice expressing human immunodeficiency virus
type 1 proteins under the regulation of the myelin basic protein gene promoter. Nat. Med. 2:655–661. 41.
18. Gravel, M., D. DeAngelis, and P. E. Braun. 1994. Molecular cloning and
characterization of rat brain 2 ,3 -cyclic nucleotide 3 -phosphodiesterase isoform 2. J. Neurosci. Res. 38:243–247.
19. Gyorkey, F., J. L. Melnick, and P. Gyorkey. 1987. Human immunodeficiency 42.
virus in brain biopsies of patients with AIDS and progressive encephalopathy. J. Infect. Dis. 155:870–876. 43.
20. Hanna, Z., D. G. Kay, N. Rebai, A. Guimond, S. Jothy, and P. Jolicoeur.
1998. Nef harbors a major determinant of pathogenicity for an AIDS-like
disease induced by HIV-1 in transgenic mice. Cell 95:163–175.
21. Hanna, Z., X. Weng, D. G. Kay, J. Poudrier, C. Lowell, and P. Jolicoeur. 44.
2001. The pathogenicity of human immunodeficiency virus (HIV) type 1 Nef
in CD4C/HIV transgenic mice is abolished by mutation of its SH3-binding 45.
domain, and disease development is delayed in the absence of Hck. J. Virol.
75:9378–9392. 46.
22. Katsuki, M., M. Sato, M. Kimura, M. Yokoyama, K. Kobayashi, and T.
Nomura. 1988. Conversion of normal behavior to shiverer by myelin basic
protein antisense cDNA in transgenic mice. Science 241:593–595.
23. Kay, D. G., P. Yue, Z. Hanna, S. Jothy, E. Tremblay, and P. Jolicoeur. 2002. 47.
Cardiac disease in transgenic mice expressing human immunodeficiency vi- rus-1 Nef in cells of the immune system. Am. J. Pathol. 161:321–335.
24. Kimura, M., M. Sato, A. Akatsuka, S. Nozawa-Kimura, R. Takahashi, M. 48.
Yokoyama, T. Nomura, and M. Katsuki. 1989. Restoration of myelin formation by a single type of myelin basic protein in transgenic shiverer mice.
Proc. Natl. Acad. Sci. USA 86:5661–5665. 49.
25. Koenig, S., H. E. Gendelman, J. M. Orenstein, M. C. Dal Canto, G. H. Y. M.
Pezeshkpour, F. Janotta, A. Aksamit, M. A. Martin, and A. S. Fauci. 1986.
Detection of AIDS virus in macrophages in brain tissue from AIDS patients 50.
with encephalopathy. Science 233:1089–1093.
26. Korber, B. T., K. J. Kunstman, B. K. Patterson, M. Furtado, M. McEvilly,
and R. Levy, and S. M. Wolinsky. 1994. Genetic differences between blood- 51.
and brain-derived viral sequences from human immunodeficiency virus type
1-infected patients: evidence of conserved elements in the V3 region of the
envelope protein of brain-derived sequences. J. Virol. 68:7467–7481.
27. Lappe-Siefke, C., S. Goebbels, M. Gravel, E. Nicksch, J. Lee, P. E. Braun, 52.
I. R. Griffiths, and K. A. Nave. 2003. Disruption of Cnp1 uncouples oligodendroglial functions in axonal support and myelination. Nat. Gen. 33:366–374.
28. Levine, J. M., R. Reynolds, and J. W. Fawcett. 2001. The oligodendrocyte 53.
precursor cell in health and disease. Trends Neurosci. 24:39–47.
29. Li, J., Y. Liu, I. W. Park, and J. J. He. 2002. Expression of exogenous Sam68,
the 68-kilodalton SRC-associated protein in mitosis, is able to alleviate 54.
impaired Rev function in astrocytes. J. Virol. 76:4526–4535.
Mangasarian, A., and D. Trono. 1997. The multifaceted role of HIV Nef.
Res. Virol. 148:30–33.
